Emcure Pharmaceuticals Ltd on Tuesday, December 23, said it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...
Emcure Pharmaceuticals Ltd. has launched Poviztra, a semaglutide injection for chronic weight management, marking its entry into the fast-growing obesity and metabolic health segment,...
Novo Nordisk India has entered into a strategic partnership with Emcure Pharmaceuticals to launch Poviztra®, the second brand of Wegovy® (semaglutide injection 2.4 mg),...
Emcure Pharmaceuticals Ltd and Sanofi India Ltd have announced a distribution and promotion partnership on Wednesday (July 16) aimed at expanding access to Sanofi’s oral anti-diabetic...